Norris Medicines Limited (BOM:524414)

Norris Medicines Revenue

In the fiscal year ending March 31, 2026, Norris Medicines had annual revenue of 81.32M INR with 39.72% growth. Norris Medicines had revenue of 14.08M in the quarter ending March 31, 2026, a decrease of -48.24%.

• Revenue: 81.32M
• Revenue Growth: +39.72%
• P/S Ratio: 1.67
• Revenue / Employee: 2.46M
• Employees: 33
• Market Cap: 135.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	81.32M	23.12M	39.72%
Mar 31, 2025	58.20M	1.85M	3.27%
Mar 31, 2024	56.36M	-27.23M	-32.58%
Mar 31, 2023	83.59M	-10.80M	-11.44%
Mar 31, 2022	94.38M	-28.13M	-22.96%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error